
Chondromed (Хондромед) inj 200 mg/2 ml 10 ampules — chondroitin sulfate
What it is
-
The active ingredient is Chondroitin sulfate (sodium salt form) — a major component of cartilage matrix. It is marketed by Lekfarm ООО (Belarus) in forms including:
-
Solution for intramuscular injection: 200 mg/2 ml (i.e., 100 mg/ml).
-
-
It is classified under “chondroprotective / metabolic agents for cartilage and bone tissue”.
How it works (Pharmacology)
-
Chondroitin sulfate is part of the proteoglycan-collagen network in cartilage and contributes to its elasticity, resilience and mechanical properties.
-
Mechanisms of the drug include:
-
Inhibiting enzymes that degrade cartilage (e.g., metalloproteinases, hyaluronidase)
-
Reducing inflammatory mediators in joint fluid (e.g., leukotrienes, prostaglandin E₂)
-
Improving cartilage matrix synthesis and supporting cartilage repair.
-
-
Onset and distribution: after intramuscular administration, it enters the bloodstream, reaches synovial fluid and cartilage tissue.
Indications (when it’s used)
According to the manufacturer and instruction:
-
Degenerative-dystrophic diseases of joints and spine: e.g., peripheral osteoarthritis (large joints), intervertebral osteochondrosis, osteoarthrosis.
-
In injection form the solution is used to influence cartilage metabolic processes.
-
In capsule form, for internal oral therapy, to support joint health.
Dosage & administration (general)
Solution (injection form):
-
Typical adult dose: 100 mg (1 ml) intramuscularly every other day. After 4th injection and if well tolerated, up to 200 mg (2 ml) every other day.
Original: $59.99
-65%$59.99
$21.00Chondromed (Хондромед) inj 200 mg/2 ml 10 ampules — chondroitin sulfate
What it is
-
The active ingredient is Chondroitin sulfate (sodium salt form) — a major component of cartilage matrix. It is marketed by Lekfarm ООО (Belarus) in forms including:
-
Solution for intramuscular injection: 200 mg/2 ml (i.e., 100 mg/ml).
-
-
It is classified under “chondroprotective / metabolic agents for cartilage and bone tissue”.
How it works (Pharmacology)
-
Chondroitin sulfate is part of the proteoglycan-collagen network in cartilage and contributes to its elasticity, resilience and mechanical properties.
-
Mechanisms of the drug include:
-
Inhibiting enzymes that degrade cartilage (e.g., metalloproteinases, hyaluronidase)
-
Reducing inflammatory mediators in joint fluid (e.g., leukotrienes, prostaglandin E₂)
-
Improving cartilage matrix synthesis and supporting cartilage repair.
-
-
Onset and distribution: after intramuscular administration, it enters the bloodstream, reaches synovial fluid and cartilage tissue.
Indications (when it’s used)
According to the manufacturer and instruction:
-
Degenerative-dystrophic diseases of joints and spine: e.g., peripheral osteoarthritis (large joints), intervertebral osteochondrosis, osteoarthrosis.
-
In injection form the solution is used to influence cartilage metabolic processes.
-
In capsule form, for internal oral therapy, to support joint health.
Dosage & administration (general)
Solution (injection form):
-
Typical adult dose: 100 mg (1 ml) intramuscularly every other day. After 4th injection and if well tolerated, up to 200 mg (2 ml) every other day.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
What it is
-
The active ingredient is Chondroitin sulfate (sodium salt form) — a major component of cartilage matrix. It is marketed by Lekfarm ООО (Belarus) in forms including:
-
Solution for intramuscular injection: 200 mg/2 ml (i.e., 100 mg/ml).
-
-
It is classified under “chondroprotective / metabolic agents for cartilage and bone tissue”.
How it works (Pharmacology)
-
Chondroitin sulfate is part of the proteoglycan-collagen network in cartilage and contributes to its elasticity, resilience and mechanical properties.
-
Mechanisms of the drug include:
-
Inhibiting enzymes that degrade cartilage (e.g., metalloproteinases, hyaluronidase)
-
Reducing inflammatory mediators in joint fluid (e.g., leukotrienes, prostaglandin E₂)
-
Improving cartilage matrix synthesis and supporting cartilage repair.
-
-
Onset and distribution: after intramuscular administration, it enters the bloodstream, reaches synovial fluid and cartilage tissue.
Indications (when it’s used)
According to the manufacturer and instruction:
-
Degenerative-dystrophic diseases of joints and spine: e.g., peripheral osteoarthritis (large joints), intervertebral osteochondrosis, osteoarthrosis.
-
In injection form the solution is used to influence cartilage metabolic processes.
-
In capsule form, for internal oral therapy, to support joint health.
Dosage & administration (general)
Solution (injection form):
-
Typical adult dose: 100 mg (1 ml) intramuscularly every other day. After 4th injection and if well tolerated, up to 200 mg (2 ml) every other day.











